DE3867560D1 - Verwendung von azidothymidin zur behandlung der psoriasis. - Google Patents

Verwendung von azidothymidin zur behandlung der psoriasis.

Info

Publication number
DE3867560D1
DE3867560D1 DE8888109039T DE3867560T DE3867560D1 DE 3867560 D1 DE3867560 D1 DE 3867560D1 DE 8888109039 T DE8888109039 T DE 8888109039T DE 3867560 T DE3867560 T DE 3867560T DE 3867560 D1 DE3867560 D1 DE 3867560D1
Authority
DE
Germany
Prior art keywords
azidothymidine
dosage forms
disclosed
therapeutically effective
effective amounts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888109039T
Other languages
English (en)
Inventor
Madeleine Duvic
Gary W Brewton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System filed Critical University of Texas System
Application granted granted Critical
Publication of DE3867560D1 publication Critical patent/DE3867560D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/04—Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DE8888109039T 1987-06-09 1988-06-07 Verwendung von azidothymidin zur behandlung der psoriasis. Expired - Lifetime DE3867560D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/059,907 US4804651A (en) 1987-06-09 1987-06-09 Methods and compositions for the treatment of psoriasis

Publications (1)

Publication Number Publication Date
DE3867560D1 true DE3867560D1 (de) 1992-02-20

Family

ID=22026060

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888109039T Expired - Lifetime DE3867560D1 (de) 1987-06-09 1988-06-07 Verwendung von azidothymidin zur behandlung der psoriasis.

Country Status (15)

Country Link
US (1) US4804651A (de)
EP (1) EP0301206B1 (de)
JP (1) JP2510675B2 (de)
KR (1) KR950014447B1 (de)
AT (1) ATE71301T1 (de)
AU (1) AU606423B2 (de)
DE (1) DE3867560D1 (de)
DK (1) DK310188A (de)
ES (1) ES2038716T3 (de)
GR (1) GR3003785T3 (de)
HU (1) HU200693B (de)
IE (1) IE61091B1 (de)
MY (1) MY103734A (de)
PH (1) PH26517A (de)
ZA (1) ZA884056B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527779A (en) * 1988-03-23 1996-06-18 Top Gold Pty Limited Topically applied gold organic complex
ATE168698T1 (de) * 1988-05-27 1998-08-15 Us Health Zubereitungen zur verwendung bei der behandlung von psoriasis und von neuropsychiatrischen krankheiten
US5098899A (en) * 1989-03-06 1992-03-24 Trustees Of Boston University Method for therapeutically treating psoriatic arthritis using vitamin D analogues and metabolites
JP2831030B2 (ja) * 1989-05-12 1998-12-02 学校法人城西大学 ３’‐アジド‐３’デオキシチミジンを有効成分とする経皮投与製剤用組成物
US5021422A (en) * 1989-06-08 1991-06-04 Senetek Plc Method and composition for treating hyperproliferative skin diseases using 6-aminopurine cytokinins
US5162361A (en) * 1990-04-10 1992-11-10 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Method of treating diseases associated with elevated levels of interleukin 1
DK0663831T3 (da) * 1991-12-13 1995-07-26 Searle & Co Transdermal azidothymidin
US5654286A (en) * 1993-05-12 1997-08-05 Hostetler; Karl Y. Nucleotides for topical treatment of psoriasis, and methods for using same
US5973010A (en) * 1998-05-15 1999-10-26 Crawford; Robert L. Composition for healing skin wounds
GR1003491B (el) * 1999-12-21 2000-11-30 Μεθοδος παρασκευης φαρμακοτεχνικου σκευασματος, αλοιφης η κρεμασκαι χρηση του στην αντιμετωπιση και θεραπεια της ψωριασεως και του εκζεματος
CA2644311C (en) * 2006-03-01 2012-07-10 Tristrata, Inc. Composition and method for topical treatment of tar-responsive dermatological disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0199451B1 (de) * 1985-03-16 1996-03-06 The Wellcome Foundation Limited Therapeutische Nukleoside
FI881216A (fi) * 1987-03-16 1988-09-17 Wellcome Found Terapeutiska nukleosider.

Also Published As

Publication number Publication date
PH26517A (en) 1992-08-07
IE881708L (en) 1988-12-09
EP0301206A2 (de) 1989-02-01
EP0301206B1 (de) 1992-01-08
GR3003785T3 (de) 1993-03-16
US4804651A (en) 1989-02-14
MY103734A (en) 1993-09-30
DK310188A (da) 1988-12-12
KR950014447B1 (ko) 1995-11-28
HU200693B (en) 1990-08-28
DK310188D0 (da) 1988-06-08
EP0301206A3 (en) 1989-09-06
AU1751088A (en) 1988-12-15
KR890000093A (ko) 1989-03-11
JP2510675B2 (ja) 1996-06-26
AU606423B2 (en) 1991-02-07
ES2038716T3 (es) 1995-04-01
JPS6470417A (en) 1989-03-15
ZA884056B (en) 1989-06-28
ATE71301T1 (de) 1992-01-15
HUT47853A (en) 1989-04-28
IE61091B1 (en) 1994-09-21

Similar Documents

Publication Publication Date Title
US5098899A (en) Method for therapeutically treating psoriatic arthritis using vitamin D analogues and metabolites
US5654312A (en) Treatment of inflammatory and/or autoimmune dermatoses with thalidomide alone or in combination with other agents
US4654373A (en) Pharmaceutical formulations containing coenzyme Q10 suitable for topic administration
US4743597A (en) Composition comprising an oxygenated cholesterol and use thereof for topical treatment of diseases
FR2364030A1 (fr) Compositions pharmaceutiques a base d'anthocyanidines et procede pour leur preparation
EP0391905A1 (de) Hämorrhoidenzusammensetzung und sonstige zusammensetzungen sowie behandlungsverfahren.
CA2120367A1 (en) Compositions and use of pharmaceutical compositions in the treatment of symptoms of disorders related to chronic inflammatory diseases and etiologically related symptomology
DE3867560D1 (de) Verwendung von azidothymidin zur behandlung der psoriasis.
WO1990004967A3 (de) Topische salbe
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
Collier et al. Topical 5‐aminosalicylic acid: a treatment for aphthous ulcers
US3629412A (en) Topical anti-inflammatory agent
Lassus Colloidal silicic acid for the treatment of psoriatic skin lesions, arthropathy and onychopathy. A pilot study
ES2096203T3 (es) Nuevos derivados de fisostigmina, su uso y formulaciones farmaceuticas que los contienen.
DE69434002D1 (de) 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis
ATE91890T1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
JP2640492B2 (ja) 皮膚外用剤
US4751236A (en) Method for treating genital herpes
Langner et al. 13-cis-retinoic acid and tetracycline versus 13-cis-retinoic acid alone in the treatment of nodulocystic acne
Vena et al. Topical 5-fluorouracil in the treatment of discoid lupus erythematosus. Preliminary study over two years
JPH0222729B2 (de)
BR0013552A (pt) Azatioprina tópica para o tratamento de doenças auto-imunes orais
EP0734726A2 (de) Zusammensetzung welche Quecksilberammoniumchlorid, Resorzin und Schwefel enthält

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: THE WELLCOME FOUNDATION LTD., GREENFORD, MIDDLESEX

8328 Change in the person/name/address of the agent

Free format text: TER MEER STEINMEISTER & PARTNER GBR PATENTANWAELTE, 81679 MUENCHEN